Registry assessing gender differences in hospitalized heart failure patients in Santiago
Gender Specific Registry in Subjects Hospitalized With Heart Failure in Santiago( GENESIS Registry): Pilot Heart Failure Registry Looking for Sex Analysis
This study looks at how heart failure affects men and women differently in hospitalized patients in Santiago, Chile, to better understand their treatment and outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Fundacion de la Sociedad Chilena de Cardiologia y Cirugia Cardiovascular Academic / other |
| Locations | 1 site (Santiago, Santiago Metropolitan) |
| Trial ID | NCT05960968 on ClinicalTrials.gov |
What this trial studies
This observational registry aims to evaluate sex-related differences in the presentation, management, and prognosis of heart failure in patients admitted to hospitals in Santiago, Chile. The study will recruit approximately 500 patients over one year from two hospitals equipped with coronary units and cardiac imaging capabilities. Data will be collected through a descriptive cross-sectional survey, with informed consent obtained from all participants. The study will adhere to ethical guidelines and will be approved by the relevant ethics committees.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older who are hospitalized with a diagnosis of acute or chronic heart failure requiring cardiovascular therapy.
Not a fit: Patients with acute Covid-19 infections or severe psychiatric disorders that impair assessment will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of gender-specific factors in heart failure, leading to improved treatment strategies for patients.
How similar studies have performed: While there have been studies on heart failure, this specific focus on gender differences in a Chilean population is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: * Patient with ≥ 18 years old * Signed informed consent * Admitted to the hospital with a : * 1\) diagnosis of acute HF as the leading cause of admission, and in which a CV therapy is needed and prescribed (ie. diuretic, vasodilator, inotropic, device), or * 2\) diagnosis of chronic HF is established during the patient hospitalization based on clinical, biochemical and/or imaging studies, and in which cardiovascular therapy is needed and prescribed (ie. diuretic, vasodilator, inotropic, device ) during the hospitalization. Exclusion criteria: * The patient presents a Covid 19 acute infection and/ or severe acute respiratory syndrome (SARS) -CoV 2 pneumonia is confirmed * The patient presents a psychiatric decompensated disorder and/or a cognitive impairment which preclude assessment of this survey.
Where this trial is running
Santiago, Santiago Metropolitan
- Paola Varleta — Santiago, Santiago Metropolitan, Chile (Recruiting)
Study contacts
- Principal investigator: Paola Varleta, Md — Fundacion de la Sociedad Chilena de Cardiologia y Cirugia Cardiovascular
- Study coordinator: Paola Varleta, Md
- Email: pao.varleta@gmail.com
- Phone: +569 95390767
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.